Sort   by:  
 Page size 
UnknownPhase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.
Not available
S-EPMC4879709 | biostudies-literature
UnknownPhase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors.
Not available
S-EPMC7845944 | biostudies-literature
TranscriptomicsImmune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.
Although remission rates for metastatic melanoma are generally very poor, some patients can survive for prolonged periods following metastasis. We used gene expression profiling, mitotic index (MI), and quantification of tumor infiltrating leukocytes (TILs) and CD3+ cells in metastatic lesions to se...
ORGANISM(S): Homo sapiens 
2009-11-30 | E-GEOD-19234 | biostudies-arrayexpress
UnknownPhase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor.
Not available
S-EPMC4878037 | biostudies-literature
UnknownImmune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Not available
ORGANISM(S): Homo sapiens 
S-ECPF-GEOD-19234 | biostudies-other
UnknownDo Patients Want their Families or their Doctors to Make Treatment Decisions in the Event of Incapacity, and Why?
Not available
S-EPMC5609846 | biostudies-literature
UnknownExtended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma.
Not available
S-EPMC6942621 | biostudies-literature
UnknownNivolumab and ipilimumab versus ipilimumab in untreated melanoma.
Not available
S-EPMC5744258 | biostudies-literature
UnknownSurrogate Perspectives on Patient Preference Predictors: Good Idea, but I Should Decide How They Are Used.
Not available
S-EPMC9761590 | biostudies-literature
TranscriptomicsClinical relevance of SKP2 alterations in metastatic melanoma
Melanoma cell lines were genotyped to evaluate copy number differences between nodular melanoma (NM) and superficial spreading melanoma (SSM). Cell lines were also evaluated for copy number alterations in the SKP2/p27 axis. Affymetrix SNP arrays were performed according to manufacturer's instruction...
ORGANISM(S): Homo sapiens 
2010-10-21 | E-GEOD-22305 | biostudies-arrayexpress
Sort   by:  
 Page size